BOLD Stocks

Medizone International, Inc. (OTCBB: MZEI) Potential to Eliminate 99.999992% Anthrax in 90 Minutes

Medizone International, Inc. (OTCBB:  MZEI) has a secondary focus in addition to Hospital Acquired Infections;  Bioterrorism Applications.  This provides an second revenue source for the company delivering enhanced shareholder  value.

A field hardened version of AsepticSure™  is anticipated to be used in Bioterrorism internationally.  It will be easily deployable in response to virtually any terrorist assault, extremely effective against a broad range of lethal pathogens, easy to manage and maintain and has the potential to save lives.  The potential of being able to eliminate 99.999992% (7.2 log kill) of an internationally accepted surrogate for Anthrax in 90 minutes will have national security implications.

Why Medizone?

• Medizone has a 23 year history in the field of medical therapeutics with Ozone.
• Medizone has initiated a joint program with Biozone Corporation to develop a state-of-the-art Ozone-based sterilization system (AsepticSure™) for medical applications.
• This technology will feature a new “Ozone Destruct” scrubbing system intended to rapidly detoxify hospital working spaces following exposure to Ozone.
• The Medizone technology (AsepticSure™) will have an Ozone producing capacity significantly greater than what is thought to be necessary under normal hospital circumstances.
• The AsepticSure™ system will also include a gas vaporization component, and a stand alone Ozone scrubbing system, adaptable to all hospital environments and space requirements.
• The AsepticSure™ will be marketed for bioterrorism applications

Contact information:
Medizone International, Inc. (OTCBB: MZEI)
(See Medizone International Video)
http://www.medizoneint.com

Telephone:  415-868-0300
Fax:  415-868-2344
Address:
Post Office Box 742
Stinson Beach, CA 94970

Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated seventy-two hundred dollars and 450,000 144 restricted common shars by the company for profile coverage for the period ending September 15, 2009. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.